Id2.16.840.1.113883.10.20.22.4.23
ref
ccda-
Gültigkeit ab2013‑01‑31
Statusdraft EntwurfVersions-Label1.1
NameMedicationInformationBezeichnungMedication Information
Beschreibung
en-US The medication can be recorded as a pre-coordinated product strength, product form, or product concentration (e.g., “metoprolol 25mg tablet”, “amoxicillin 400mg/5mL suspension”) or not pre-coordinated (e.g., “metoprolol product”).
KontextElternknoten des Template-Element mit Id 2.16.840.1.113883.10.20.22.4.23
KlassifikationCDA Entry Level Template
Offen/GeschlossenOffen (auch andere als die definierten Elemente sind erlaubt)
Benutzt von / Benutzt
Benutzt von 7 Transactions und 36 Templates, Benutzt 0 Templates
Benutzt von als NameVersion
2.16.840.1.113883.3.1937.99.3.4.4Transaktionfinal en-US Progress Note (Release 1.1)2013‑01‑31
2.16.840.1.113883.3.1937.99.3.4.3Transaktionfinal en-US Discharge Summary (Release 1.1)2013‑01‑31
2.16.840.1.113883.3.1937.99.3.4.5Transaktionfinal en-US Procedure Note (US Realm – Release 1)2013‑01‑31
2.16.840.1.113883.3.1937.99.3.4.2Transaktionfinal en-US Consultation Notes (Release 1.1)2013‑01‑31
2.16.840.1.113883.3.1937.99.3.4.1Transaktionfinal en-US Continuity of Care Document (CCD) (Release 1.1)2013‑01‑31
2.16.840.1.113883.3.1937.99.3.4.6Transaktionfinal en-US Operative Note (Release 1.1)2013‑01‑31
2.16.840.1.113883.3.1937.99.3.4.7Transaktionfinal en-US History and Physical (H and P) (Release 1.1)2013‑01‑31
2.16.840.1.113883.3.1937.99.61.26.10.52linkdraft Procedure Activity Procedure (1.1)2019‑03‑06 11:55:46
2.16.840.1.113883.3.1937.99.61.41.10.4linkdraft Discharge Summary (1.1)2018‑02‑19 15:30:38
2.16.840.1.113883.3.1937.777.24.10.14Containmentdraft Medication Activity (1.1)2019‑01‑16 10:56:33
2.16.840.1.113883.10.20.22.1.2linkdraft Continuity of Care Document (CCD) (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.1.3linkdraft History and Physical (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.1.4linkdraft Consultation Note (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.1.6linkdraft Procedure Note (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.1.7linkdraft Operative Note (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.1.8linkdraft Discharge Summary (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.1.9linkdraft Progress Note (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.2.1linkdraft Medications Section (entries optional) (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.2.1.1linkdraft Medications Section (entries required) (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.2.2linkdraft Immunizations Section (entries optional) (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.2.2.1linkdraft Immunizations Section (entries required) (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.2.6linkdraft Allergies Section (entries optional) (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.2.6.1linkdraft Allergies Section (entries required) (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.2.7linkdraft Procedures Section (entries optional) (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.2.7.1linkdraft Procedures Section (entries required) (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.2.11linkdraft Hospital Discharge Medications Section (entries optional) (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.2.11.1linkdraft Hospital Discharge Medications Section (entries required) (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.2.25linkdraft Anesthesia Section (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.2.38linkdraft Medications Administered Section (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.2.44linkdraft Hospital Admission Medications Section (entries optional) (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.4.7linkdraft Allergy - Intolerance Observation (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.4.9linkdraft Reaction Observation (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.4.12linkdraft Procedure Activity Act (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.4.13linkdraft Procedure Activity Observation (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.4.14linkdraft Procedure Activity Procedure (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.4.16Containmentdraft Medication Activity (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.4.17Containmentdraft Medication Supply Order (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.4.18Containmentdraft Medication Dispense (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.4.30linkdraft Allergy Problem Act (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.4.35linkdraft Discharge Medication (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.4.36linkdraft Admission Medication (1.1)2013‑01‑31
2.16.840.1.113883.10.20.22.4.52linkdraft Immunization Activity (1.1)2013‑01‑31
2.16.840.1.113883.10.20.24.3.90linkdraft Substance or Device Allergy - Intolerance Observation (1.1)2013‑01‑31
ItemDTKardKonfBeschreibungLabel
cda:manufacturedProduct
Medidotstion
@classCode
cs1 … 1FMANUconf‑7408
cda:templateId
II1 … 1Men-US SHALL contain exactly one [1..1] templateId (CONF:7409) such that itconf‑7409
@root
uid1 … 1F2.16.840.1.113883.10.20.22.4.23confdots0506
cda:id
II0 … *en-US MAY contain zero or more [0..*] id (CONF:7410).conf‑7410
cda:manufacturedMaterial
1 … 1Men-US SHALL contain exactly one [1..1] manufacturedMaterial (CONF:7411).conf‑7411
cda:code
CE1 … 1en-US This manufacturedMaterial SHALL contain exactly one [1..1] code, which SHALL be selected from ValueSet Medication Clinical Drug Name Value Set 2.16.840.1.113883.3.88.12.80.17 DYNAMIC (CONF:7412).conf‑7412
 CONF
Der Wert von @code muss gewählt werden aus dem Value Set 2.16.840.1.113883.3.88.12.80.17 Medication Clinical Generic Drug (DYNAMIC)
cda:originalText
0 … 1Ren-US This code SHOULD contain zero or one [0..1] originalText (CONF:7413).conf‑7413
cda:reference
0 … 1Ren-US The originalText, if present, SHOULD contain zero or one [0..1] reference (CONF:15986).

This reference/@value SHALL begin with a '#' and SHALL point to its corresponding narrative (using the approach defined in CDA Release 2, section 4.3.5.1)		confdots5986
@value
0 … 1 confdots5987
 Schematron assertrolered error 
 testnot(@value) or starts-with(@value, '#') 
 MeldungThis reference/@value SHALL begin with a '#' and SHALL point to its corresponding narrative (using the approach defined in CDA Release 2, section 4.3.5.1) 
cda:translation
CD0 … *en-US This code MAY contain zero or more [0..*] translation (CONF:7414).

Translations can be used to represent generic product name, packaged product code, etc.		conf‑7414
cda:manufacturerOrganization
0 … 1en-US MAY contain zero or one [0..1] manufacturerOrganization (CONF:7416).conf‑7416